Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event

Contributed by: ACCESS Newswire

Logo

Tags

Healthcare & Pharmaceutical

Moderna, Inc.

NASDAQ:MRNA

ESG

More Like This

Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025

Moderna Awarded Tender for the Supply of Its mRNA COVID-19 Vaccine in the European Union

PR Newswire associated0

Corporates Continue to Embed Sustainability in Core Business Strategies

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

PR Newswire associated0

Montrose Environmental Group Releases 2023 Sustainability Report

The report discloses PCI's performance, targets, and strategy to achieve nine identified impact categories. (Photo: Business Wire)

Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union

PR Newswire associated0

Montrose Environmental Group Releases 2023 Sustainability Report Executive Summary